Angiotensin-Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors
- 1 September 2009
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 54 (3) , 468-470
- https://doi.org/10.1161/hypertensionaha.109.135244
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated AngioedemaHypertension, 2009
- Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme InhibitorsHypertension, 2008
- Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated AngioedemaHypertension, 2008
- Efficacy and Safety of Incretin Therapy in Type 2 DiabetesJAMA, 2007
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesPublished by Elsevier ,2006
- Incidence and Characteristics of Angioedema Associated With EnalaprilArchives of internal medicine (1960), 2005
- Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trialPublished by Oxford University Press (OUP) ,2004
- Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosaThe FASEB Journal, 2002
- Vasopeptidase inhibition and angio-oedemaThe Lancet, 2000
- CD26, let it cut or cut it downPublished by Elsevier ,1999